Peptides like epitalon and MOTS-c are often sold with a promise that they can slow aging or help you live longer. The sales pages usually point to “studies.” Before you spend money, it helps to know how to read those claims. You don’t need a science degree. You just need a few good questions.
Start with who, or what, was studied
A lot of longevity research happens in dishes of cells, in worms, in flies or in mice. That work is important, but it is early. Many things that help a mouse never help a person. Some turn out to cause harm.
So the first question is simple: was this tested in humans? If the answer is no, the claim is a hypothesis, not a result. And if it was tested in people, ask whether they were like you in ways that matter, such as age, sex and health.
Check the size, length and design
Bigger studies are usually more trustworthy than small ones. A study with a handful of people can show a “result” just by chance.
Length matters too. Aging happens over decades. A study that lasts a few weeks can’t tell you whether something extends life, or whether it causes problems that show up later.
The strongest design is a randomized controlled trial. People are randomly split into groups, and one group gets the real product while another gets a placebo or standard care. This helps keep bias out of the results. Many longevity claims rest on studies that don’t use this design at all.
Follow the money
Ask who paid for the research. A company that sells a peptide may profit if a study looks good. That doesn’t mean the study is wrong, but it is a reason to look for independent work that confirms it.
Also notice who is telling you about the study. A seller’s summary is not the same as the study itself.
Know where these peptides stand with the FDA
No peptide is FDA-approved to slow aging or extend life. In April 2026, the FDA removed epitalon, MOTS-c and several other peptides from its list of compounding substances with significant safety risks. That happened because the requests were withdrawn, not because they were found safe. It did not make them eligible for compounding.
In July 2026, an FDA advisory committee voted to recommend adding several peptides, including MOTS-c and epitalon, to the list pharmacies can compound from. FDA staff had recommended against it. The votes are advisory, and as of October 2026 there is no final FDA decision.
Products sold online now are typically labeled “for research use only.” They are not made under drug-quality rules and can contain the wrong dose, the wrong substance or contaminants. Certificates of analysis can be copied or faked.
The bottom line
When a peptide promises a longer life, read the evidence like a careful shopper. Was it tested in people? Was the study large, long and randomized? Who paid for it? If the answers are thin, the claim is too. For real gains in healthy aging, a clinician can help you focus on steps with strong evidence behind them, and can talk through any product you are considering.